title: Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine.
abstract: Human papillomavirus (HPV)-induced cutaneous warts are potentially serious and debilitating. In immunosuppressed patients, these warts may be resistant to standard therapies. We report a case of a young patient with a primary immune deficiency whose recalcitrant cutaneous warts regressed completely following administration of a quadrivalent HPV vaccine.
authors.affiliation: Department of Dermatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
authors.forename: S P
authors.identifier: http://orcid.org/0000-0001-7744-3238
authors.initials: SP
authors.lastname: Smith
authors.affiliation: Department of Clinical Immunology, Papworth Hospital NHS Foundation Trust, Papworth, UK.|Department of Medicine, University of Cambridge, Cambridge, UK.
authors.forename: H E
authors.initials: HE
authors.lastname: Baxendale
authors.affiliation: Department of Dermatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.|Department of Medicine, University of Cambridge, Cambridge, UK.
authors.forename: J C
authors.initials: JC
authors.lastname: Sterling
mesh_terms: D000293:Adolescent; D006229:Hand Dermatoses / Q000628:therapy* / Q000821:virology; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / Q000008:administration & dosage*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D008297:Male; D030361:Papillomavirus Infections / Q000628:therapy*; D016896:Treatment Outcome; D014860:Warts / Q000628:therapy* / Q000821:virology
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18